Use access key #2 to skip to page content.
$21.47 -0.23 (-1.06%)
1/9/2009 4:00 PM

Endo Pharmaceuticals (ENDP)

CAPS Rating:
****

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

View All Commentary (ENDP)

Recs

0

Avatar StatsGeek (99.99) Submitted: 5/22/07 1:59 AM : Outperform Start Price: $34.75 ENDP Score: 3.46

This stock has two things I find attractive:

1) Relatively inexpensive,

2) Trading up on high volume with some call option activity suggests that could be an acquisition target. A lot of the big pharmas need to buy growth companies, and they need to do it while the antitrust environment is still favorable.

We'll see.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links